Valuation : QuidelOrtho Corporation

Market Cap 918M 790M 743M 677M 1.27B 87.31B 1.27B 8.81B 3.41B 44.48B 3.45B 3.37B 141B P/E 2026 *
-3.25x
P/E 2027 * -4.83x
Enterprise Value 3.63B 3.12B 2.94B 2.68B 5.01B 345B 5.03B 34.86B 13.47B 176B 13.63B 13.34B 558B EV / Sales 2026 *
1.43x
EV / Sales 2027 * 1.37x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-4.30%
1 week-7.60%
Current month-10.67%
1 month-6.25%
3 months-7.53%
6 months-35.10%
Current year-54.87%
1 week 12.78
Extreme 12.78
14.43
1 month 12.07
Extreme 12.0657
15.52
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
77.44
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap. Importance
15/08/26 Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
15/07/26 Free

Chief Financial Officer

356,555 0.5251%
06/07/26 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-4.33%-7.60%-54.87%-82.70% 918M
-0.55%-3.74%+18.99%-29.90% 17.12B
-2.34%+6.87%-32.09%+54.17% 1.75B
-1.27%-2.35%-28.08%+24.33% 918M
+0.08%+0.19%+59.66%-2.91% 779M
-1.94%-3.55%-34.99%-47.28% 679M
-2.30%-1.25%-42.24%-44.83% 619M
+2.90%-19.62%-46.42%-42.22% 420M
-2.09%-6.78%+70.44%+48.84% 405M
-0.74%-1.11%-10.46%-8.21% 404M
Average -1.25%-4.12%-10.00%-13.07% 2.4B
Weighted average by Cap. -0.91%-3.18%+8.10%-22.25%

Financials

2026 *2027 *
Net sales 2.54B 2.19B 2.06B 1.88B 3.51B 242B 3.53B 24.43B 9.44B 123B 9.55B 9.35B 391B 2.59B 2.23B 2.1B 1.91B 3.58B 247B 3.59B 24.89B 9.62B 126B 9.73B 9.52B 398B
Net income -282M -242M -228M -208M -389M -26.79B -390M -2.7B -1.04B -13.65B -1.06B -1.03B -43.24B -190M -164M -154M -140M -263M -18.11B -264M -1.83B -706M -9.23B -715M -699M -29.23B
Net Debt 2.71B 2.33B 2.2B 2B 3.75B 258B 3.76B 26.05B 10.07B 132B 10.19B 9.96B 417B 2.62B 2.26B 2.13B 1.94B 3.63B 250B 3.64B 25.2B 9.74B 127B 9.85B 9.64B 403B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
09/09/26 $12.88 -3.74% 338,561
08/09/26 $13.38 -4.22% 961,619
04/09/26 $13.97 +0.29% 890,257
03/09/26 $13.93 -0.14% 836,790
02/09/26 $13.95 +1.45% 834,462
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
13.38USD
Average target price
14.67USD
Spread / Average Target
+9.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!